Alan Wheeldon

Behavioral and Neurochemical Alterations in Mice Deficient in Anaplastic Lymphoma Kinase Suggest Therapeutic Potential for Psychiatric Indications

James Bilsland, Alan Wheeldon, Andrew Mead et al. · Neuropsychopharmacology · 2007 · 185 citations · Full text

Neurochemical Alterations, Psychoneuroimmunology, Psychopathology +14

Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice

N.M.J. Rupniak, E.C Carlson, Timothy Harrison et al. · Neuropharmacology · 2000 · 171 citations

Molecular Pharmacology, Neonatal Vocalisation, Genetic Deletion +10

Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs

N.M.J. Rupniak, Emma Carlson, J.K. Webb et al. · Behavioural Pharmacology · 2001 · 150 citations

Nk1 Receptor, Nk1r−/− Mice, Nk 1 +19

Functional characterization of three adenosine receptor types

M.F. Gurden, Jill Coates, F. Ellis et al. · British Journal of Pharmacology · 1993 · 138 citations · Full text

The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia

Catriona Hay, Michael A. Trevethick, Alan Wheeldon et al. · Neuroscience · 1997 · 135 citations

Inflammation, Complete Adjuvant-induced Changes, Spinal Cord Injury +15